middle.news
Can Universal Biosensors Overcome Cash Crunch Despite 6% Revenue Growth?
2:44am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Can Universal Biosensors Overcome Cash Crunch Despite 6% Revenue Growth?
2:44am on Monday 2nd of June, 2025 AEST
Key Points
6% year-over-year revenue growth driven by Sentia and Petrackr products
Net loss widened to A$3.84 million amid increased R&D spending
Laboratory testing services revenue declined 22% due to leadership challenges
Cash and equivalents at A$4.92 million, runway only into Q3 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Universal Biosensors (ASX:UBI)
OPEN ARTICLE